ReviewCancers2024

Efficacy and Safety of Sorafenib or Lenvatinib for Advanced Hepatocellular Carcinoma after Failure of First-Line Atezolizumab Plus Bevacizumab: A Systematic Review and Meta-Analysis.

Tzu-Rong Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.